| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 13,234,366 | 11,368,349 | 8,922,524 | | Cost of Revenue | 5,240,393 | 3,826,828 | 2,910,675 | | | Gross Profit | 7,993,973 | 7,541,521 | 6,011,849 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 209,485 | 431,206 | 575,785 | | Non Recurring | (42,552) |
-
|
-
| | Others | 7,301,691 | 3,000,094 | 2,108,352 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 525,349 | 4,110,221 | 3,327,712 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 418,970 | (1,112,165) | (4,291) | | Earnings Before Interest And Taxes | 6,054,602 | 3,030,676 | 3,323,421 | | Interest Expense | 104,742 | 281,354 | 120,134 | | Income Before Tax | 5,949,859 | 2,749,322 | 3,203,287 | | Income Tax Expense | 1,679,152 | 329,266 | 969,653 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (839,576) | 2,387,435 | 2,233,634 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (6,865) | | Other Items |
-
|
-
|
-
| | | | Net Income | (839,576) | 2,387,435 | 2,226,770 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($839,576) | $2,387,435 | $2,226,770 |
|
1.48% Nasdaq 
Income Statement
